| Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis AJ Van Der Meer, BJ Veldt, JJ Feld, H Wedemeyer, JF Dufour, F Lammert, ... Jama 308 (24), 2584-2593, 2012 | 1863 | 2012 |
| Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection JG McHutchison, GT Everson, SC Gordon, IM Jacobson, M Sulkowski, ... New England Journal of Medicine 360 (18), 1827-1838, 2009 | 1420 | 2009 |
| Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus BJ Veldt, W Chen, EJ Heathcote, H Wedemeyer, J Reichen, WP Hofmann, ... Hepatology 47 (6), 1856-1862, 2008 | 365 | 2008 |
| Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis MAA Claassen, RJ de Knegt, HW Tilanus, HLA Janssen, A Boonstra Journal of hepatology 52 (3), 315-321, 2010 | 172 | 2010 |
| Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial M Conchillo, RJ de Knegt, M Payeras, J Quiroga, B Sangro, JI Herrero, ... Journal of hepatology 43 (4), 630-636, 2005 | 139 | 2005 |
| Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C C Verveer, PE Zondervan, FJW ten Kate, BE Hansen, HLA Janssen, ... Liver International 32 (4), 622-628, 2012 | 108 | 2012 |
| Biochemical and biophysical assessment of MTX‐induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan® predicts the absence … MAM Berends, J Snoek, EMGJ De Jong, JH Van Krieken, RJ De Knegt, ... Liver International 27 (5), 639-645, 2007 | 102 | 2007 |
| Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis RJ de Knegt, SW Schalm, CCD van der Rijt, D Fekkes, E Dalm, ... Journal of hepatology 20 (1), 19-26, 1994 | 102 | 1994 |
| Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C R Roomer, BE Hansen, HLA Janssen, RJ de Knegt Hepatology 52 (4), 1225-1231, 2010 | 79 | 2010 |
| Thrombocytopenia and the risk of bleeding during treatment with peginterferon alfa and ribavirin for chronic hepatitis C R Roomer, BE Hansen, HLA Janssen, RJ de Knegt Journal of hepatology 53 (3), 455-459, 2010 | 79 | 2010 |
| Clinical implications of chronic hepatitis E virus infection in heart transplant recipients L Koning, SD Pas, RA de Man, AHMM Balk, RJ de Knegt, FJ ten Kate, ... The Journal of Heart and Lung Transplantation 32 (1), 78-85, 2013 | 73 | 2013 |
| Randomized placebo controlled phase I/II trial of α-galactosylceramide for the treatment of chronic hepatitis C BJ Veldt, HJJ van der Vliet, BME von Blomberg, H Van Vlierberghe, ... Journal of hepatology 47 (3), 356-365, 2007 | 73 | 2007 |
| Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients KJM Stibbe, C Verveer, J Francke, BE Hansen, PE Zondervan, EJ Kuipers, ... Scandinavian journal of gastroenterology 46 (7-8), 962-972, 2011 | 69 | 2011 |
| Crigler‐Najjar syndrome in The Netherlands: Identification of four novel UGT1A1 alleles, genotype–phenotype correlation, and functional analysis of 10 missense … N Sneitz, CT Bakker, RJ de Knegt, DJJ Halley, M Finel, PJ Bosma Human mutation 31 (1), 52-59, 2010 | 67 | 2010 |
| Randomised clinical trial: anti‐viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV JF Bergmann, J de Bruijne, DM Hotho, RJ de Knegt, A Boonstra, ... Alimentary pharmacology & therapeutics 34 (4), 443-453, 2011 | 66 | 2011 |
| Treatment of chronic hepatitis C virus infection-Dutch national guidelines J De Bruijne, EH Buster, HC Gelderblom, JT Brouwer, RJ De Knegt, ... Neth J Med 66 (7), 311-22, 2008 | 61 | 2008 |
| Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patients J de Bruijne, JF Bergmann, HW Reesink, CJ Weegink, R Molenkamp, ... Hepatology 52 (5), 1590-1599, 2010 | 60 | 2010 |
| Treatment of chronic hepatitis B virus infection-Dutch national guidelines EH Buster, KJ Van Erpecum, SW Schalm, HL Zaaijer, JT Brouwer, ... Neth J Med 66 (7), 292-306, 2008 | 54 | 2008 |
| Retention of CD4+ CD25+ FoxP3+ Regulatory T Cells in the Liver after Therapy-Induced Hepatitis C Virus Eradication in Humans MAA Claassen, RJ de Knegt, HLA Janssen, A Boonstra Journal of virology 85 (11), 5323-5330, 2011 | 53 | 2011 |
| Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study G Bezemer, AR Van Gool, E Verheij-Hart, BE Hansen, Y Lurie, JI Esteban, ... BMC gastroenterology 12, 1-7, 2012 | 51 | 2012 |
